Patent · US Active

Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases

US9132280B2 · kind B2 · utility

0Cited by

4References

7Claims

0Family size

Assignee

UNIVERSITY OF SOUTH CAROLINA · US

Inventors

Brian Furmanski · Columbia, US
Roy E. Wuthier · Columbia, US
John W. Fuseler · Columbia, US

Key dates

Filing date	Dec 27, 2012
Grant date	Sep 15, 2015
Priority date	—
Expiry date	May 30, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K41/0057
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of photodynamic therapy to treat diseased cells in an animal is generally provided. According to the method, 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is administered to the animal such that the 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof accumulates in the diseased cells. Then, the diseased cells containing 5-amino-2,2-dimethyl-6-[3′-(R,S)amino-4′-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is exposed to light energy (e.g., ultraviolet light).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.